Sarepta Therapeutics, Inc.
SRPT· Nasdaq
SRPTSarepta Therapeutics, Inc.
Filed Nov 12, 2013 · 10-Q · 43 days after period end · 0001193125-13-436840
| Metric | Q3 2013 | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|---|
| Net Income | -$42.03M | -$49.55M | -$4.02M | -$7.29M |
| EPS Diluted | -$1.24 | -$2.17 | -$0.18 | -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sarepta Therapeutics, Inc. · CIK 873303 · Engraved from SEC EDGAR
ended Sep 30, 2013 · filed Nov 12, 2013 · 43 d after period end
